TY - JOUR
T1 - Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity
AU - Kaplan, Anat Levit
AU - Confair, Danielle N.
AU - Kim, Kuglae
AU - Barros-Álvarez, Ximena
AU - Rodriguiz, Ramona M.
AU - Yang, Ying
AU - Kweon, Oh Sang
AU - Che, Tao
AU - McCorvy, John D.
AU - Kamber, David N.
AU - Phelan, James P.
AU - Martins, Luan Carvalho
AU - Pogorelov, Vladimir M.
AU - DiBerto, Jeffrey F.
AU - Slocum, Samuel T.
AU - Huang, Xi Ping
AU - Kumar, Jain Manish
AU - Robertson, Michael J.
AU - Panova, Ouliana
AU - Seven, Alpay B.
AU - Wetsel, Autumn Q.
AU - Wetsel, William C.
AU - Irwin, John J.
AU - Skiniotis, Georgios
AU - Shoichet, Brian K.
AU - Roth, Bryan L.
AU - Ellman, Jonathan A.
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2022/10/20
Y1 - 2022/10/20
N2 - There is considerable interest in screening ultralarge chemical libraries for ligand discovery, both empirically and computationally1–4. Efforts have focused on readily synthesizable molecules, inevitably leaving many chemotypes unexplored. Here we investigate structure-based docking of a bespoke virtual library of tetrahydropyridines—a scaffold that is poorly sampled by a general billion-molecule virtual library but is well suited to many aminergic G-protein-coupled receptors. Using three inputs, each with diverse available derivatives, a one pot C–H alkenylation, electrocyclization and reduction provides the tetrahydropyridine core with up to six sites of derivatization5–7. Docking a virtual library of 75 million tetrahydropyridines against a model of the serotonin 5-HT2A receptor (5-HT2AR) led to the synthesis and testing of 17 initial molecules. Four of these molecules had low-micromolar activities against either the 5-HT2A or the 5-HT2B receptors. Structure-based optimization led to the 5-HT2AR agonists (R)-69 and (R)-70, with half-maximal effective concentration values of 41 nM and 110 nM, respectively, and unusual signalling kinetics that differ from psychedelic 5-HT2AR agonists. Cryo-electron microscopy structural analysis confirmed the predicted binding mode to 5-HT2AR. The favourable physical properties of these new agonists conferred high brain permeability, enabling mouse behavioural assays. Notably, neither had psychedelic activity, in contrast to classic 5-HT2AR agonists, whereas both had potent antidepressant activity in mouse models and had the same efficacy as antidepressants such as fluoxetine at as low as 1/40th of the dose. Prospects for using bespoke virtual libraries to sample pharmacologically relevant chemical space will be considered.
AB - There is considerable interest in screening ultralarge chemical libraries for ligand discovery, both empirically and computationally1–4. Efforts have focused on readily synthesizable molecules, inevitably leaving many chemotypes unexplored. Here we investigate structure-based docking of a bespoke virtual library of tetrahydropyridines—a scaffold that is poorly sampled by a general billion-molecule virtual library but is well suited to many aminergic G-protein-coupled receptors. Using three inputs, each with diverse available derivatives, a one pot C–H alkenylation, electrocyclization and reduction provides the tetrahydropyridine core with up to six sites of derivatization5–7. Docking a virtual library of 75 million tetrahydropyridines against a model of the serotonin 5-HT2A receptor (5-HT2AR) led to the synthesis and testing of 17 initial molecules. Four of these molecules had low-micromolar activities against either the 5-HT2A or the 5-HT2B receptors. Structure-based optimization led to the 5-HT2AR agonists (R)-69 and (R)-70, with half-maximal effective concentration values of 41 nM and 110 nM, respectively, and unusual signalling kinetics that differ from psychedelic 5-HT2AR agonists. Cryo-electron microscopy structural analysis confirmed the predicted binding mode to 5-HT2AR. The favourable physical properties of these new agonists conferred high brain permeability, enabling mouse behavioural assays. Notably, neither had psychedelic activity, in contrast to classic 5-HT2AR agonists, whereas both had potent antidepressant activity in mouse models and had the same efficacy as antidepressants such as fluoxetine at as low as 1/40th of the dose. Prospects for using bespoke virtual libraries to sample pharmacologically relevant chemical space will be considered.
UR - http://www.scopus.com/inward/record.url?scp=85139098126&partnerID=8YFLogxK
U2 - 10.1038/s41586-022-05258-z
DO - 10.1038/s41586-022-05258-z
M3 - Article
C2 - 36171289
AN - SCOPUS:85139098126
SN - 0028-0836
VL - 610
SP - 582
EP - 591
JO - Nature
JF - Nature
IS - 7932
ER -